Get the Stockscreener App
3.23
6.38%
-0.22
After Hours:
3.25
0.02
+0.62%
Aclarion Inc stock is traded at $3.23, with a volume of 45,311.
It is down -6.38% in the last 24 hours and up +20.52% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$3.45
Open:
$3.45
24h Volume:
45,311
Relative Volume:
0.06
Market Cap:
$7.37M
Revenue:
$75,700
Net Income/Loss:
$-7.23M
P/E Ratio:
-0.1877
EPS:
-17.2081
Net Cash Flow:
$-7.37M
1W Performance:
-2.71%
1M Performance:
+20.52%
6M Performance:
-59.78%
1Y Performance:
-83.99%
1-Day Range:
$3.03
$3.45
1-Week Range:
$3.03
$3.595
52-Week Range:
$2.3401
$18.36
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, BTSG, TEM, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
3.23 | 7.87M | 75,700 | -7.23M | -7.37M | -17.21 |
VEEV
Veeva Systems Inc
|
178.11 | 29.44B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
44.82 | 8.32B | 12.91B | 104.80M | 394.69M | 0.8769 |
TEM
Tempus Ai Inc
|
46.76 | 8.73B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.47 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.14 | 4.61B | 1.10B | 112.09M | 283.19M | 0.6096 |
Aclarion Inc Stock (ACON) Latest News
Macro Review: Should I hold or sell Aclarion Inc Equity Warrant now2026 Price Swings & Fast Moving Market Watchlists - baoquankhu1.vn
Echo Lake Capital Calls for the Resignation of David Neal From the Board of Directors of Aclarion Inc. - Bitget
Investment Review: Is Aclarion Inc. still a buy after recent gains2026 Review & Stepwise Trade Signal Guides - baoquankhu1.vn
Targets Report: Is Aclarion Inc still a buy after recent gainsPortfolio Update Summary & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Aclarion, Inc. Adopts One-Year Stockholder Rights Plan to Protect Shareholder Value and Prevent Hostile Takeovers - Minichart
Aclarion adopts one-year stockholder rights plan By Investing.com - Investing.com India
Aclarion Adopts One-Year Stockholder Rights Protection Plan - TipRanks
Aclarion (NASDAQ: ACON) sets 10% trigger in one-year rights plan - Stock Titan
Aclarion adopts one-year stockholder rights plan - Investing.com
Aclarion installs 1-year takeover defense, keeps door open to fair bids - Stock Titan
Shareholder Letter From Chief Executive Officer Brent Ness - 富途牛牛
Aclarion, Inc. Pursues Insurance Reimbursement Initiatives and Reports Strong Momentum Leading into 2026 - Quiver Quantitative
Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts - Bluefield Daily Telegraph
Aclarion targets US insurers as back-pain trial readout nears - Stock Titan
Aclarion : Shareholder Letter from Chief Executive Officer Brent Ness - marketscreener.com
Aclarion, Inc. Revolutionizes Low Back Pain Diagnosis with MR Spectroscopy and AI-Powered NOCISCAN Platform 798083 - Minichart
Published on: 2026-03-19 07:53:44 - baoquankhu1.vn
Aclarion (NASDAQ: ACON) expands NOCISCAN spine diagnostics and AI plans - Stock Titan
Aclarion 10-K: Revenue $0.076M, EPS (13.61) — Annual Report Highlights - TradingView
ACON: Revenue up 65.6% to $75.7K; net loss $7.2M; $22.6M raised in 2025, $10.4M in 2026 - TradingView
Aclarion, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Published on: 2026-03-19 06:54:42 - baoquankhu1.vn
Aclarion to Present at ROTH Conference, Showcasing Nociscan Technology for Chronic Back Pain Diagnosis - citybuzz -
Is Aclarion Inc Equity Warrant still a buy after recent gainsQuarterly Profit Report & Safe Entry Trade Reports - baoquankhu1.vn
Aclarion, Inc. to Engage with Investors at the 38th Annual ROTH Conference Regarding Nociscan Advancements - Quiver Quantitative
Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet - Bitget
Back pain scan firm Aclarion meets investors at ROTH with no debt - Stock Titan
Investment Review: Whats the outlook for Aclarion Inc Equity Warrants sectorWeekly Market Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Aug Shorts: Is Aclarion Inc Equity Warrant benefiting from interest rate changes2026 Technical Overview & Consistent Profit Alerts - baoquankhu1.vn
Aclarion CEO to Present AI-Powered Back Pain Diagnostic Technology at Leading MedTech Conference - citybuzz -
Aclarion CEO Brent Ness to Attend LSI USA 2026 - Bitget
Aclarion, Inc. CEO Brent Ness to Attend LSI USA 2026 to Discuss NOCISCAN and Industry Partnerships - Quiver Quantitative
Back pain imaging firm Aclarion courts partners at LSI USA 2026 - Stock Titan
Quarterly Risk: Is Aclarion Inc Equity Warrant stock undervalued right nowQuarterly Profit Review & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Decliners Report: Is Aclarion Inc Equity Warrant attractive for institutional investorsTrade Volume Report & Growth-Oriented Investment Plans - baoquankhu1.vn
What is Aclarion Inc Equity Warrants 5 year growth outlookJuly 2025 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Will Aclarion Inc. stock benefit from upcoming earnings reports2026 Chart Watch & Proven Capital Preservation Methods - Naître et grandir
Aug EndMonth: How Aclarion Inc. Equity Warrant stock reacts to job market dataTrade Analysis Report & Accurate Buy Signal Notifications - Naître et grandir
Dividend Watch: Will Aclarion Inc Equity Warrant outperform during market rallies2025 Analyst Calls & Breakout Confirmation Alerts - baoquankhu1.vn
Analyst Calls: Will Aclarion Inc Equity Warrant outperform during market ralliesIndex Update & Consistent Return Strategy Ideas - baoquankhu1.vn
Bank Watch: Does Five Below Inc stock have upside surprise potentialMarket Activity Recap & Safe Entry Momentum Tips - baoquankhu1.vn
Retail Trends: Whats next for CalciMedica Inc stock2025 Sector Review & Technical Entry and Exit Tips - baoquankhu1.vn
ACON PE Ratio & Valuation, Is ACON Overvalued - Intellectia AI
Activity Recap: Is Tidewater Inc forming a breakout patternWeekly Market Outlook & Weekly Top Stock Performers List - baoquankhu1.vn
ACON Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Volatility Watch: Is Aclarion Inc still a buy after recent gainsTrade Risk Summary & High Return Stock Watch Alerts - baoquankhu1.vn
Trading Recap: Whats the outlook for Aclarion Inc Equity Warrants sectorJuly 2025 Summary & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Investor Mood: Is Aclarion Inc Equity Warrant still a buy after recent gains - baoquankhu1.vn
Market Wrap: Is Aclarion Inc Equity Warrant stock undervalued right now2025 Big Picture & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Can Aclarion Inc. Equity Warrant stock continue upward trend2025 Key Lessons & Safe Entry Momentum Stock Tips - mfd.ru
US Market Wrap: Should I hold or sell Aclarion Inc. Equity Warrant now2025 Short Interest & Stepwise Entry and Exit Trade Signals - mfd.ru
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.33%
5.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):